OKYO Pharma Limited

OKYO | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.35

+$0.02 (+1.50%)

At close: Sep 22, 2026, 4:00 PM ET

$1.33

-$0.02 (-1.48%)

After-hours: Sep 22, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.50%

(1D)

Rating

Updated: Aug 11, 2026

28.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $51.8M

1D Range

1.31 1.36

52W Range

1.28 3.20

Valuation (TTM)

PE -7

PB 4.14

EV/EBITDA -3.31

Valuation (NTM)

Forward PE N/A

Forward PEG -0.03

Price Target $5

Cash Flow

FCF Yield -11.6%

SBC Adj. FCF Yield -11.6%

SBC Impact N/A

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 46.3% | -14.3%

FCF 3Y | 5Y -4.3% | -41.5%

Returns

ROA -42.7%

ROE -200.7%

ROIC -74.6%

Financial Health

Net Cash

$20.59M

Current Ratio 2.43

Interest Coverage -20.81

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

OKYO Pharma Limited is a biopharmaceutical firm operating at the preclinical stage, dedicated to developing innovative treatments for individuals in the United Kingdom experiencing inflammatory eye co...

Sector Healthcare

Industry Biotechnology

Employees 5

IPO Date May 16, 2022

Website www.okyopharma.com

Fiscal Year April - March

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+270.37%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞